Hoggan Biotech Consulting

Hoggan Biotech Consulting provides expert clinical development strategy and support to biotech companies globally. Led by Tom Hoggan, the firm has advised on over 100 projects across various therapeutic areas, including rare diseases and RNA therapies. The consultancy specializes in designing evidence-based clinical development plans, regulatory strategy for FDA/EMA/MHRA submissions, indication selection, trial design (including basket trials), and commercial planning for both start-ups and established biotechs.

Example outcomes include developing global regulatory strategies for rare disease assets with no current treatments and designing efficient early-phase trials for novel RNA products.

The company does not conduct its own research or maintain an internal drug pipeline.

[No direct clinical results as it’s a service provider.]